Physician
Hematology
Dr. Matthew J. Olnes, MD
|
|
Give Review
Matthew Olnes practices Hematology. He studied medicine at Uniformed Services University of the Health Sciences. Uniformed Services University of the Health Sciences is ranked 72 in research and 47 in primary care medicine Dr. Matthew J. Olnes is a published doctor. He has 24 papers published. The most current publication "2,3,7,8-tetrachlorodibenzo-p-dioxin modulates expression of the prostaglandin G/H synthase-2 gene in rat thymocytes." He is registered with Medicare and accepts Medicare payments.
Publications
- Clinical activity and safety of the dual pathway inhibitor rigosertib for higher risk Myelodysplastic syndromes following DNA methyltransferase inhibitor therapy.
- Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T cells and natural killer cells in healthy volunteers.
- Global Analyses of human immune variation reveal baseline predictors of postvaccination responses.
- Eltrombopag restores tri-lineage hematopoiesis in refractory severe aplastic Anemia which can be sustained on discontinuation of drug.
- Baseline levels and tempOral stability of 27 multiplexed serum cytokine concentrations in healthy subjects.
- Immunomodulatory treatment of Myelodysplastic syndromes: antithymocyte globulin, cyclosporine, and alemtuzumab.
- Eltrombopag and improved hematopoiesis in refractory aplastic Anemia.
- Directed therapy for patients with Myelodysplastic syndromes (MDS) by suppression of cyclin D1 with ON 01910.Na.
- FISHing for aneuploidy in HSCT donors.
- Effects of granulocyte-colony-stimulating factor on Monosomy 7 aneuploidy in healthy hematopoietic stem cell and granulocyte donors.
- T-cell immune responses to Wilms tumor 1 protein in myelodysplasia responsive to immunosuppressive therapy.
- Targeting immune dysregulation in Myelodysplastic syndromes.
- Alemtuzumab treatment of intermediate-1 myelodysplasia patients is associated with sustained improvement in blood counts and cytogenetic remissions.
- A Non-ATP-Competitive Dual Inhibitor of JAK2 and BCR-ABL Kinases: Elucidation of a Novel Therapeutic Spectrum Based on Substrate Competitive Inhibition.
- Nonconvulsive status epilepticus resulting from benzodiazepine withdrawal.
- Hematologic malignancies with extramedullary spread of disease. Case 3. Extra-nodal Hodgkin's disease presenting as rapidly progressive Liver failure.
- Improvement in hemolysis and pulmonary arterial systolic pressure in adult patients with sickle cell disease during treatment with hydroxyurea.
- Long-term follow-up of patients with moderate aplastic Anemia and pure red cell aplasia treated with daclizumab.
- A review and update on cholangiocarcinoma.
- Interdigitating dendritic cell Sarcoma: a rare malignancy responsive to ABVD chemotherapy.
- 2,3,7,8-tetrachlorodibenzo-p-dioxin modulates expression of the prostaglandin G/H synthase-2 gene in rat thymocytes.
- Promoter of the canine tracheobronchial mucin gene.
- Primary structure of the canine U1 snRNA.
Schools
Uniformed Services University of The Health Sciences
Johns Hopkins University School Med
Conditions Treated
- Anal and Rectal Cancer
- Anemia
- Bile Duct Cancer
- Bladder Cancer
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
National Institutes of Health Clinical Center -
Johns Hopkins University -
Uniformed Services University of the Health Sciences
Drug Facts
| NPI NUMBER | 1396760021 | |
| NPPES Provider LastName | OLNES | |
| NPPES Provider FirstName | MATTHEW | |
| NPPES Provider ZIPCode | 995085926 | |
| NPPES Provider State | AK | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 354.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 39.0 | |
| Percent Opioid Claims | 11.02 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1396760021 |
| Last Name Of The Provider | OLNES |
| First Name Of The Provider | MATTHEW |
| View All |
Similar Doctors
|
|
Dr. Steven Y. Liu, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary L. Stewart, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Malcolm I. Bull, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark Levandovsky, MD |
|
|
Dr. Verneeda Spencer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dennis D. Beckworth, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Megan C. Davies, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James M. Sprott Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sang I. Shin, MD |
|
|
Dr. Ellen H. Chirichella, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Susan C. Delgalvis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Max J. Rabinowitz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sharon M. Tobias, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeanne E. Anderson, MD
This Doctor is OpenDoctor Recommended.
|